drugset
drugset / Trial / NCT06960694

Effect of L-carnitine on Disease Activity in Patients With Mild to Moderate Knee Osteoarthritis

NCT06960694 ↗

Phase 2 Completed 66 enrolled Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to evaluate the effects of L-carnitine on symptomatic improvement, oxidative stress, and inflammation in mild to moderate knee osteoarthritis patients.

Timeline

Start
2025-06-28
Primary completion
2025-11-19
Completion
2025-11-19

Drugs

EvaluationDrugModalityDoseRoute
Subject L-carnitine Other / unclassified 330 mg —

Indications

osteoarthritis, knee